Found 1 clinical trials
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)
The objectives of this study are to evaluate the safety and efficacy of Zimura intravitreal administration in patients with geographic atrophy secondary to age-related macular degeneration (AMD)
maculopathy
geographic atrophy
macular degeneration
age-related macular degeneration
complement c5
- 0 views
- 16 Feb, 2024
- 23 locations